A Randomized, Placebo Controlled, Double Masked Phase IB Study Evaluating the Safety and Antiviral Activity of Aprepitant, a Neurokinin-1 Receptor Antagonist in HIV-1 Infected Adults

• Pablo Tebas ,

  * E-mail: Pablo.tebas@uphs.upenn.edu

  Affiliation Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Florin Tuluc,

  Affiliation The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America

  ⨯
• Jeffrey S. Barrett,

  Affiliation The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America

  ⨯
• Wayne Wagner,

  Affiliation Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Deborah Kim,

  Affiliation Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Huaquing Zhao,

  Affiliation Westat, Rockville, Maryland, United States of America

  ⨯
• René Gonin,

  Affiliation Westat, Rockville, Maryland, United States of America

  ⨯
• James Korelitz,

  Affiliation Westat, Rockville, Maryland, United States of America

  ⨯
• Steven D. Douglas

  Affiliation The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America

  ⨯